Percutaneous intervention versus Anticoagulation in Atrial fibrillation.

被引：0
|
作者：
Jakob, Alexander H.
机构：
来源：
MEDIZINISCHE KLINIK | 2010年 / 105卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Anticoagulation for atrial fibrillation. The future has begun
    Moser, M.
    Bode, C.
    INTERNIST, 2012, 53 (01): : 30 - 35
  • [2] The effect of literacy and anticoagulation knowledge on the adequacy of warfarin anticoagulation for patients with atrial fibrillation.
    Bryant, B
    Malone, R
    Ayscue, D
    DeWalt, DA
    Pignone, M
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 169 - 169
  • [3] Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
    Kiviniemi, Tuomas
    Karjalainen, Pasi
    Rubboli, Andrea
    Schlitt, Axel
    Tuomainen, Petri
    Niemela, Matti
    Laine, Mika
    Biancari, Fausto
    Lip, Gregory Y. H.
    Airaksinen, K. E. Juhani
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (04): : 493 - 498
  • [4] Anticoagulation in geriatric patients with atrial fibrillation. With what and for whom no more?
    Bahrmann, P.
    Christ, M.
    HERZ, 2018, 43 (03) : 214 - 221
  • [5] Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future
    Schimpf, T
    Stellbrink, C
    MEDIZINISCHE KLINIK, 2003, 98 (02) : 91 - 95
  • [6] Anticoagulation in atrial fibrillation. A large real-world update
    Bo, Mario
    Fumagalli, Stefano
    Degli Esposti, Luca
    Perrone, Valentina
    Dovizio, Melania
    Poli, Daniela
    Marcucci, Rossella
    Verdecchia, Paolo
    Reboldi, Gianpaolo
    Lip, Gregory Y. H.
    Ungar, Andrea
    Boccanelli, Alessandro
    Fumagalli, Carlo
    Marchionni, Niccolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 121 : 88 - 94
  • [7] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12): : 1139 - 1151
  • [8] Dabigatran versus warfarin in patients with atrial fibrillation.
    Lundelin, K.
    REVISTA CLINICA ESPANOLA, 2010, 210 (03): : 139 - 140
  • [9] Percutaneous coronary intervention in patients with atrial fibrillation.: Antithrombotic therapy and baseline clinical characteristics analysis
    Ruiz-Nodar, J. M.
    Brouzet, T. A.
    Hurtado, J.
    Valencia, J.
    Jimeno, J. R.
    Pineda, J.
    Valdes, M.
    Sogorb, F.
    Lip, G. Y. H.
    Marin, F.
    CIRCULATION, 2008, 118 (12) : E279 - E279
  • [10] Pharmacogenomics of atrial fibrillation.
    Donahue, BS
    Darbar, D
    George, AL
    Li, C
    Brown, NJ
    Ritchie, M
    Roden, DM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P7 - P7
12345